Il-33 promotes mhc class ii expression in murine mast cells

Keyphrases

• Mast Cells 100%
• Interleukin-33 (IL-33) 100%
• Bone Marrow-derived Mast Cell 46%
• MHC Class II 26%
• CIITA 26%
• PU.1 20%
• Degranulation 13%
• Allergic Diseases 13%
• Chromatin Immunoprecipitation (ChIP) 13%
• Prolonged Exposure 13%
• Atopic Dermatitis 13%
• Quantitative PCR 6%
• Cell-to-cell 6%
• CD40 6%
• Surface Expression 6%
• Dendritic Cells 6%
• T Cells 6%
• Transactivation 6%
• Type 2 Immune Response 6%
• Costimulatory Molecules 6%
• FcεRI 6%
• IL-1 Family Cytokines 6%
• Histone Acetylation 6%
• Monocytes 6%
• Murine Model 6%
• T Cell Activation 6%
• C-kit 6%
• Programmed Death-ligand 1 (PD-L1) 6%
• CD80 6%
• Etiology 6%
• Tissue-resident Cells 6%
• Syngeneic 6%
• Cell Lineage 6%
• Murine Bone Marrow 6%
• CD86 6%
• Pathological Manifestations 6%
• Western Blotting 6%
• MHC Class II Expression 6%

Immunology and Microbiology

• Mast Cell 100%
• Interleukin-33 100%
• Bone Marrow Derived Mast Cell 50%
• MHC Class II 35%
• CIITA 28%
• Cytokine 14%
• Degranulation 14%
• Chromatin Immunoprecipitation 14%
• Atopic Dermatitis 14%
• Maturation 7%
• Western Blot 7%
• Cell Surface 7%
• Interleukin-1 7%
• Dendritic Cell 7%
• T Cell 7%
• Transactivation 7%
• Immune Response 7%
• Coculture 7%
• Cell Lineage 7%
• Histone Acetylation 7%
• T Cell Activation 7%
• Fluorescence Activated Cell Sorting 7%
• CD86 7%
• Real Time Polymerase Chain Reaction 7%
• Co-Stimulatory Molecule 7%
• CD80 7%
• Syngenic 7%